JPRN-UMIN000029478
Recruiting
N/A
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancer - Breast Cancer II
QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology0 sites30 target enrollmentOctober 10, 2017
Conditionsbreast cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Severe complication (e.g. uncontroled lung disease, heart disease, infection, or psychiatric disease). 2\. Previous treatment history including surgery, chemotherapy, endocrine therapy, molecular\-targeted agents for breast cancer in same side. 3\. Active other malignancy 4\. The distanse between skin surface and tumor (including EIC) \<\=5 mm. 5\. Previous radiation therapy for breast cancer in same side. 6\. Eligible patients for "Breast cancer I". 7\. Pregnancy, pregnancy potential. 8\. Ptinents who are considered inappropriate by the attending physician due to medical, psychological or other factors.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerBreast cancerD001943JPRN-jRCTs032180154Karasawa Kumiko30
Active, Not Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerBreast cancerD001943JPRN-jRCTs032180153Karasawa Kumiko20
Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using proton for early breast cancerJPRN-UMIN000016206Fukui Prefectural Hospital20
Recruiting
Phase 1
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerJPRN-UMIN000010848ational Institute of Radiological Sciences20
Active, Not Recruiting
Phase 1
A study to investigate the effect of addition of metformin to standard treatment in patients with inoperable stage III non-small cell lung cancer.EUCTR2017-004877-15-BEAntwerp University Hospital, Department Thoracic Oncology104